4.0 Review

Concurrent chemoradiation for high-risk prostate cancer

Journal

WORLD JOURNAL OF CLINICAL ONCOLOGY
Volume 6, Issue 4, Pages 35-42

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v6.i4.35

Keywords

Prostate cancer; Chemoradiation; Highrisk prostate cancer; Concurrent chemotherapy; Chemotherapy; Intensity modulated radiation therapy

Categories

Ask authors/readers for more resources

There are estimated to be 220800 cases of prostate cancer diagnosed in 2015, making up 26% of all cancer diagnoses. Fortunately, adenocarcinoma of the prostate is often a highly treatable malignancy. Even though the majority of prostate cancer patients present with localized disease, prostate cancer still accounts for over 27000 deaths a year. There is a subset of patients that

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available